“Kaizen” as the Basis of Validation Innovation

As biomanufacturing innovation continues, drug manufacturers face many challenges to identify efficacious new products and to support these products with processes that will successfully scale-up or -out. Bioprocessing demands ongoing improvements that can differ around the world. To ensure that all pieces and steps in a bioprocess consistently meet a manufacturer’s and regulator’s expectations,…

Read the full article here

Related Articles